A new study showed that SOCS1 regulation of GM-CSF signaling is dose-dependent. The study, which involved generating a novel ...

Regulatory ApprovalFormycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® 15.01.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...

Formycon and Fresenius Kabi announce MHRA approval for FYB202/Otulfi® (ustekinumab), a biosimilar to Stelara® Otulfi ® received MHRA approval for both subcutaneous and intravenous formulations, to ...

Summary: Tocilizumab is a novel monoclonal antibody that competitively inhibits the binding of interleukin-6 (IL-6) to its receptor (IL-6R). Inhibiting the entire receptor complex prevents IL-6 ...

Cells producing interleukin-6 (IL-6) and the actions of IL-6 in the body. Ig = immunoglobulin, CRP = C-reactive protein, SAA = serum amyloid A protein. Reprinted, with permission, from reference 21.

The Company expects that its cash and cash equivalents of approximately $103M (unaudited) as of December 31, 2024, will be ...

Jane Street Group LLC bought a new stake in XBiotech Inc. (NASDAQ:XBIT – Free Report) in the 3rd quarter, according to its ...

ARCALYST® (rilonacept) 2024 net product revenue of $416.4 million (unaudited), representing ~79% year-over-year growth –– ARCALYST 2025 net ...

Think salmon, mackerel, sardines, or any other option that is naturally oily. These fish are packed with omega-3 fatty acids, ...

CALGARY, Alberta, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Applications are now open for Foresight Canada's 2025 Cleantech Awards, ...

The FDA has approved Steqeyma® (ustekinumab-stba), a biosimilar to Stelara®, for the treatment of various chronic ...

Foods that reduce inflammation include fatty fish, tea, walnuts, and more. Here, a dietitian explains the best ...